CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-28 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-12-28 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −1 | 11,999 | ||
| 2020-12-16 | Yu K Peony Chief Medical Officer | Sale | −3,350 | $41.61 | $139K | 192,292 |
| 2020-12-15 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,068 | $43.60 | $134K | 266,144 |
| 2020-12-07 | Yu K Peony Chief Medical Officer | Shares withheld for taxes | −3,292 | $41.99 | $138K | 195,642 |
| 2020-12-07 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Shares withheld for taxes | −2,728 | $41.99 | $115K | 131,767 |
| 2020-12-07 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −3,014 | $41.99 | $127K | 269,212 |
| 2020-12-07 | Chung Christine SVP, China Operations | Shares withheld for taxes | −3,039 | $41.99 | $128K | 150,576 |
| 2020-12-01 | Eisner Mark Incoming Chief Medical Officer | Grant or award | +35,000 | 35,000 | ||
| 2020-12-01 | Eisner Mark Incoming Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2020-11-17 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Exercise or conversion | +7,082 | $14.58 | $103K | 134,495 |
| 2020-11-17 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Exercise or conversion · Stock Option (Right to Buy) | −7,082 | 0 | ||
| 2020-09-16 | Yu K Peony Chief Medical Officer | Sale | −3,351 | $44.01 | $147K | 198,934 |
| 2020-09-15 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,070 | $43.63 | $134K | 272,226 |
| 2020-09-08 | Yu K Peony Chief Medical Officer | Shares withheld for taxes | −3,291 | $42.16 | $139K | 202,285 |
| 2020-09-08 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Shares withheld for taxes | −2,728 | $42.16 | $115K | 127,413 |
| 2020-09-08 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −3,014 | $42.16 | $127K | 275,296 |
| 2020-09-08 | Chung Christine SVP, China Operations | Shares withheld for taxes | −3,038 | $42.16 | $128K | 153,615 |
| 2020-09-03 | Yu K Peony Chief Medical Officer | Exercise or conversion | +10,000 | $18.00 | $180K | 215,576 |
| 2020-09-03 | Yu K Peony Chief Medical Officer | Sale | −10,000 | $50.89 | $509K | 205,576 |
Page 18 of 33 · 651 trades